Component A [Core]: Massachusetts Pregnancy Risk Assessment Monitoring System (PRAMS)

组件 A [核心]：马萨诸塞州妊娠风险评估监测系统 (PRAMS)

• 批准号: 10393199
• 负责人: Hafsatou Diop
• 金额: $ 16万
• 依托单位: MASSACHUSETTS STATE DEPT OF PUB HEALTH
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-05-01 至 2026-04-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10393199
• 关键词: Component; Core; Massachusetts; Pregnancy; Risk

PI / PD: Diop, Hafsatou RFA-DP-21-001 Project Summary/Abstract The overall goal of the Massachusetts Pregnancy Risk Assessment Monitoring System (PRAMS) is to collect data to improve the health of mothers in the preconception, perinatal, or postpartum periods and the health of their infants. Massachusetts (MA) has implemented PRAMS since 2007 and oversamples women by race/ethnicity to allow women of color to have a greater opportunity to participate in the survey. PRAMS methodology uses a mixed mode survey (mail and telephone) to inquire about maternal attitudes, experiences and behaviors before, during and shortly after pregnancy. There are approximately 70,000 births annually in MA, of which 2,400 are sampled for inclusion in PRAMS. During the last three years for which we have weighted data, the overall weighted response rate was 59.9%, 61.9%, and 62.4%, for 2016, 2017, and 2018, respectively. MA PRAMS response rates have been consistently above the CDC minimum response rate threshold of 55% during 2016-2018. PRAMS will be used to inform the Title V priorities and performance measures, and support MA maternal and child health (MCH) priorities. We propose to use PRAMS to provide reliable data to inform MCH programs with limited or nonexistent data. For example, although MA has taken a number of steps to understand and respond to the opioid epidemic, data on prescription pain relievers and other opioids during pregnancy, particularly among women who have not been diagnosed or treated for substance use disorder were lacking, as they are not captured in administrative and program data. In addition, data on whether women received substance use disorder treatment from providers including medication-assisted treatment (MAT) during pregnancy were limited. We will use the PRAMS Opioid Survey and Opioid Call-Back Survey (OCBS) to obtain these data among new mothers. In addition, the OCBS will provide a unique opportunity to ask about access to substance misuse treatment, including MAT, rehabilitation services, and other programs such as peer-to-peer support systems, and to identify best practices to mitigate the risk of opioid misuse in the postpartum period and reduce maternal opioid misuse and overdose events. Similarly, in response to the current pandemic, MA is also working on implementing a COVID-19 survey to better understand the inequities we see in the spread and treatment of COVID-19.

pi / pd：diop，hafsatou rfa-dp-21-001 项目摘要/摘要 马萨诸塞州怀孕风险评估监测的总体目标 系统（PRAM）是收集数据，以改善母亲的健康 孕前，围产期或产后时期及其婴儿的健康。 自2007年以来，马萨诸塞州（马萨诸塞州）已实施了婴儿车，由 种族/民族使有色女性有更多机会参加 民意调查。 PRAMS方法论使用混合模式调查（邮件和电话）查询 关于孕产妇的态度，经验和行为 怀孕。 MA每年大约有70,000个出生，其中2,400个 采样以包含在婴儿车中。在过去的三年中，我们加权了 数据，整体加权响应率为59.9％，61.9％和62.4％，2016年，2017年， 和2018年。 MA PRAM的回应率一直在高于 CDC最低响应率阈值在2016 - 2018年期间为55％。 婴儿车将用于告知标题V优先级和绩效指标， 并支持MA孕产妇健康（MCH）优先事项。我们建议使用婴儿车 提供可靠的数据，以有限或不存在数据的MCH程序为MCH程序提供信息。为了 例如，尽管马已经采取了许多步骤来理解和回应 阿片类药物流行，有关怀孕期间处方止痛药和其他阿片类药物的数据， 特别是在尚未被诊断或治疗药物使用的妇女中 缺乏疾病，因为它们没有在行政和程序数据中捕获。在 补充，有关妇女是否接受过药物使用障碍治疗的数据 怀孕期间包括药物辅助治疗（MAT）在内的提供者有限。 我们将使用PRAMS阿片类药物调查和阿片类药物呼叫调查（OCB）获得 这些数据之间的数据。此外，OCB将提供独特的机会 询问获得滥用药物治疗的信息，包括垫子，康复 服务以及其他程序，例如点对点支持系统，并确定最佳 练习以减轻产后滥用阿片类药物的风险并减少 产妇阿片类药物滥用和过量事件。同样，响应电流 马萨诸塞州大流行还致力于实施COVID-19，以更好地了解 我们在COVID-19的传播和治疗中看到的不平等现象。